Hes not only eating healthier and exercising more, but also using Zepbound, one of the new GLP-1 drugs, to control his appetite
Ultimately, for future clinical applications, such as evaluating the metabolic resilience of engineered CAR-T cells, relying on a single optical modality is insufficient
Access this article Similar content being viewed by others References GBD 2021 Diabetes Collaborators
Tirzepatide works by targeting GLP-1 AND GIP receptors which stimulates the release of insulin and reduces the time for the stomach to empty its contents
Complementary approaches may include: Behavioral therapy or weight management counseling Sleep optimization (79 hours nightly) Stress management techniques Evaluation and treatment of coexisting conditions (insulin resistance, sleep apnea, depression) FDA-approved oral weight loss medications (orlistat, phentermine/topiramate ER, naltrexone/bupropion) as alternatives to injectables (note: phentermine monotherapy is approved for short-term use only) Patients should maintain realistic expectationsweight loss may be slower with hypothyroidism, even when well-controlled